E B Suhler

Summary

Affiliation: Oregon Health and Science University
Country: USA

Publications

  1. pmc Characterization of serous retinal detachments in uveitis patients with optical coherence tomography
    Annamieka Simmons-Rear
    Casey Eye Institute, Oregon Health and Science University, Portland, OR, USA
    J Ophthalmic Inflamm Infect 2:191-7. 2012
  2. doi request reprint Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial
    Eric B Suhler
    Portland Veterans Administration Medical Center, Portland, Oregon, USA
    Br J Ophthalmol 97:481-6. 2013
  3. doi request reprint Incidence and prevalence of uveitis in Veterans Affairs Medical Centers of the Pacific Northwest
    Eric B Suhler
    Portland Veterans Administration Medical Center, Portland, Oregon 97239, USA
    Am J Ophthalmol 146:890-6.e8. 2008
  4. ncbi request reprint A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes
    Eric B Suhler
    Uveitis and Retina Divisions, Casey Eye Institute, 3375 SW Terwilliger Blvd, Portland, OR 97239, USA
    Arch Ophthalmol 123:903-12. 2005
  5. ncbi request reprint Prevalence of serologic evidence of cat scratch disease in patients with neuroretinitis
    E B Suhler
    Casey Eye Institute, Department of Ophthalmology, Oregon Health Sciences University, Portland 97035, USA
    Ophthalmology 107:871-6. 2000
  6. doi request reprint Rituximab for treatment of ocular inflammatory disease: a series of four cases
    P A Kurz
    Mail Code L467AD, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA
    Br J Ophthalmol 93:546-8. 2009
  7. pmc How do you know?
    J T Rosenbaum
    Casey Eye Institute, Oregon Health and Science University, 3375 SW Terwilliger Blvd, Portland, OR 97239 4197, USA
    Br J Ophthalmol 88:980-1. 2004
  8. ncbi request reprint Histopathological features of conjunctival sarcoid nodules using noninvasive in vivo confocal microscopy
    Michael S Wertheim
    Casey Eye Institute, Oregon Health and Science University, 3375 SW Terwilliger Blvd, Portland, OR 97239, USA
    Arch Ophthalmol 123:274-6. 2005
  9. ncbi request reprint In vivo confocal microscopy of keratic precipitates
    Michael S Wertheim
    Casey Eye Institute, Oregon Health and Science University, Portland 97201, USA
    Arch Ophthalmol 122:1773-81. 2004
  10. ncbi request reprint Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration
    Robert B Nussenblatt
    The National Eye Institute, Laboratory of Immunology, NIH, Building 10, 10 Center Drive, Bethesda, MD, USA
    J Autoimmun 21:283-93. 2003

Collaborators

Detail Information

Publications18

  1. pmc Characterization of serous retinal detachments in uveitis patients with optical coherence tomography
    Annamieka Simmons-Rear
    Casey Eye Institute, Oregon Health and Science University, Portland, OR, USA
    J Ophthalmic Inflamm Infect 2:191-7. 2012
    ....
  2. doi request reprint Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trial
    Eric B Suhler
    Portland Veterans Administration Medical Center, Portland, Oregon, USA
    Br J Ophthalmol 97:481-6. 2013
    ..We conducted a prospective, multicentre, open-label Phase II clinical trial to assess the effectiveness and safety of adalimumab, a fully human anti-TNF monoclonal antibody, in treating refractory uveitis...
  3. doi request reprint Incidence and prevalence of uveitis in Veterans Affairs Medical Centers of the Pacific Northwest
    Eric B Suhler
    Portland Veterans Administration Medical Center, Portland, Oregon 97239, USA
    Am J Ophthalmol 146:890-6.e8. 2008
    ..To ascertain the frequency of uveitis in Veterans Affairs (VA) patients in the Pacific Northwest and to compare disease rates with those in previously published epidemiologic studies...
  4. ncbi request reprint A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes
    Eric B Suhler
    Uveitis and Retina Divisions, Casey Eye Institute, 3375 SW Terwilliger Blvd, Portland, OR 97239, USA
    Arch Ophthalmol 123:903-12. 2005
    ..We conducted a prospective, open-label phase 2 clinical trial to assess the effectiveness of infliximab in treating refractory autoimmune uveitis...
  5. ncbi request reprint Prevalence of serologic evidence of cat scratch disease in patients with neuroretinitis
    E B Suhler
    Casey Eye Institute, Department of Ophthalmology, Oregon Health Sciences University, Portland 97035, USA
    Ophthalmology 107:871-6. 2000
    ..To determine the prevalence of Bartonella henselae seropositivity in patients with a clinical diagnosis of neuroretinitis...
  6. doi request reprint Rituximab for treatment of ocular inflammatory disease: a series of four cases
    P A Kurz
    Mail Code L467AD, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA
    Br J Ophthalmol 93:546-8. 2009
    ..The ongoing pilot study will hopefully provide additional insight into the benefit of rituximab for treatment of scleritis and idiopathic orbital inflammatory disease...
  7. pmc How do you know?
    J T Rosenbaum
    Casey Eye Institute, Oregon Health and Science University, 3375 SW Terwilliger Blvd, Portland, OR 97239 4197, USA
    Br J Ophthalmol 88:980-1. 2004
  8. ncbi request reprint Histopathological features of conjunctival sarcoid nodules using noninvasive in vivo confocal microscopy
    Michael S Wertheim
    Casey Eye Institute, Oregon Health and Science University, 3375 SW Terwilliger Blvd, Portland, OR 97239, USA
    Arch Ophthalmol 123:274-6. 2005
  9. ncbi request reprint In vivo confocal microscopy of keratic precipitates
    Michael S Wertheim
    Casey Eye Institute, Oregon Health and Science University, Portland 97201, USA
    Arch Ophthalmol 122:1773-81. 2004
    ..To evaluate the heterogeneity of keratic precipitates (KP) in varying subtypes of uveitis by in vivo confocal microscopy (IVCM)...
  10. ncbi request reprint Humanized anti-interleukin-2 (IL-2) receptor alpha therapy: long-term results in uveitis patients and preliminary safety and activity data for establishing parameters for subcutaneous administration
    Robert B Nussenblatt
    The National Eye Institute, Laboratory of Immunology, NIH, Building 10, 10 Center Drive, Bethesda, MD, USA
    J Autoimmun 21:283-93. 2003
    ..These studies suggest that anti-IL-2 receptor blockade could be useful in the treatment of Th1-mediated autoimmune conditions...
  11. pmc A double-masked, randomized study to investigate the safety and efficacy of daclizumab to treat the ocular complications related to Behçet's disease
    Ronald R Buggage
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, MD 20892 1857, USA
    Ocul Immunol Inflamm 15:63-70. 2007
    ..To investigate the safety and efficacy of daclizumab (Zenapax, humanized anti-Tac, HAT) in controlling the ocular manifestations of Behçet's disease...
  12. ncbi request reprint Biologic therapies for inflammatory eye disease
    Lyndell Lim
    Casey Eye Institute, Oregon Health and Science University, 3375 SSW Terwilliger Boulevard, Portland, Oregon 97239, USA
    Clin Experiment Ophthalmol 34:365-74. 2006
    ....
  13. ncbi request reprint HLA-B27-associated uveitis: overview and current perspectives
    Eric B Suhler
    Casey Eye Institute, Oregon Health and Science University, and Portland VA Medical Center, Ophthalmology Service, 97239, USA
    Curr Opin Ophthalmol 14:378-83. 2003
    ....
  14. ncbi request reprint Toxoplasmosis retinochoroiditis and elevated intraocular pressure: a retrospective study
    Andrew C Westfall
    Department of Ophthalmology, Casey Eye Institute, Oregon Health and Science University, Portland, Oregon 97201, USA
    J Glaucoma 14:3-10. 2005
    ..To report the prevalence of abnormal intraocular pressure (IOP) in patients with toxoplasmosis retinochoroiditis and to determine risk factors for such abnormality...
  15. doi request reprint Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study
    John H Kempen
    Center for Preventive Ophthalmology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Ophthalmic Epidemiol 15:47-55. 2008
    ....
  16. ncbi request reprint Bilateral uveitis in a patient with autoimmune lymphoproliferative syndrome
    Wee Kiak Lim
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892 1857, USA
    Am J Ophthalmol 139:562-3. 2005
    ..We report a case of autoimmune lymphoproliferative syndrome (ALPS) presenting with bilateral uveitis...
  17. ncbi request reprint Mycophenolate mofetil for the treatment of scleritis
    H Nida Sen
    Laboratory of Immunology, National Eye Institute, National Institutes of Health, Bethesda, Maryland 20892 1857, USA
    Ophthalmology 110:1750-5. 2003
    ..To evaluate the usefulness of mycophenolate mofetil (MMF) (CellCept, Roche, Nutley, NJ), an antimetabolite immunosuppressant with a selective antiproliferative effect on T and B lymphocytes, for the treatment of scleritis...
  18. pmc The role of choroidal and retinal biopsies in the diagnosis and management of atypical presentations of uveitis
    Lyndell L Lim
    Casey Eye Institute, Oregon Health and Sciences University, Portland Oregon, USA
    Trans Am Ophthalmol Soc 103:84-91; discussion 91-2. 2005
    ..The most common indication is atypical uveitis, in which a diagnosis of malignancy or infection may be suspected. Here, we describe our experience at the Casey Eye Institute...